A detailed history of Bank Of America Corp transactions in Cybin Inc. stock. As of the latest transaction made, Bank Of America Corp holds 44,000 shares of CYBN stock, worth $11,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,000
Previous 40,500 8.64%
Holding current value
$11,440
Previous $16,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.3 - $0.46 $1,050 - $1,610
3,500 Added 8.64%
44,000 $18,000
Q4 2023

Feb 14, 2024

BUY
$0.38 - $0.65 $15,390 - $26,325
40,500 New
40,500 $16,000
Q1 2023

May 12, 2023

SELL
$0.3 - $0.56 $193 - $361
-645 Reduced 71.19%
261 $0
Q4 2022

Feb 10, 2023

SELL
$0.26 - $0.47 $43 - $79
-169 Reduced 15.72%
906 $0
Q3 2022

Nov 14, 2022

SELL
$0.54 - $1.11 $454 - $933
-841 Reduced 43.89%
1,075 $0
Q4 2021

Feb 08, 2022

BUY
$1.13 - $2.31 $2,165 - $4,425
1,916 New
1,916 $2,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $43.2M
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.